Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new diabetes pill formula on healthy volunteers

NCT ID NCT07304687

Summary

This early-stage study tested how a new combination pill for type 2 diabetes (CKD-383) is absorbed and processed by the body, compared to taking its three separate drug components. It involved 31 healthy adult volunteers who each received both the single pill and the separate pills in a specific order. The main goal was to measure the drug levels in the blood and check for safety, not to treat diabetes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • H Plus Yangji Hospital

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.